Skip to content

DR. TEMPELS

Active
Private limited companyfounded 198838 yrs activeBasilieklaan 82, 3270 Scherpenheuvel-Zichem, BelgiumKBO/BCE: BE 0434.415.686
Summary

DR. TEMPELS has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.46M and a net result of €336k. Equity is growing by ~26.2% per year across the filed fiscal years. Its solvency ranks better than 86% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).

Checked score

Score 2025
96 / 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability95▲+5
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €130k at 30 days acceptable
Liquidity ample (current ratio 11.94 against 9.64 in 2024; short-term debt: 8.1% and cash: 34.6% of total assets), and 8.1% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Four signals. The signal on the left, the evidence on the right.
lowers riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 38 years 0 40 y
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
91.9%
Return on assets
21.2%
Age of the figures
15 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 14-01-2026, 17 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
17 d early
2024
43 d early
2023
49 d early
2022
on the day
2021
49 d early
2020
47 d early
2019
2 d early
← before the deadline after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close24-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€1.46M▲ 22.7%
2024 · €1.19M
2019: €329k 2020: €398k 2021: €568k 2022: €753k 2023: €1.00M 2024: €1.19M
2019 → 2025
Total assets
€1.59M▲ 20.6%
2024 · €1.31M
2019: €347k 2020: €422k 2021: €645k 2022: €809k 2023: €1.10M 2024: €1.31M
2019 → 2025
Net result
€336k▲ 47.0%
2024 · €229k
2019: €42k 2020: €68k 2021: €170k 2022: €184k 2023: €249k 2024: €229k
2019 → 2025
Working capital
€1.40M▲ 27.6%
2024 · €1.10M
2019: €306k 2020: €377k 2021: €548k 2022: €730k 2023: €894k 2024: €1.10M
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€568k-€753k▲ 32.5%€1.00M▲ 33.0%€1.19M▲ 18.6%€1.46M▲ 22.7%
Operating result€245k-€265k▲ 8.2%€356k▲ 34.1%€334k▼ 6.2%€463k▲ 38.6%
Net result€170k-€184k▲ 8.2%€249k▲ 34.8%€229k▼ 8.0%€336k▲ 47.0%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€200k€400kOperating result 2021: €245k€245kNet result 2021: €170k€170kOperating result 2022: €265k€265kNet result 2022: €184k€184kOperating result 2023: €356k€356kNet result 2023: €249k€249kOperating result 2024: €334k€334kNet result 2024: €229k€229kOperating result 2025: €463k€463kNet result 2025: €336k€336k20212022202320242025
The operating result recovers in 2025; 2025 is 39% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.59M
Fixed assets €55k ▼ 37.8%
Current assets €1.53M ▲ 24.8%
Equity and liabilities €1.59M
Equity €1.46M ▲ 22.7%
Debt €129k ▲ 1.1%
The debt ratio falls from 9.7% to 8.1%. Equity and debt are higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€481k
2024 · €360k
Cash flow
€354k
2024 · €255k
Current ratio
11.94
2024 · 9.64
Quick ratio
11.72
2024 · 9.16
Debt / equity
0.09
2024 · 0.11
ROE
23.1%
2024 · 19.2%
ROA
21.2%
2024 · 17.4%
Interest coverage
138.39
2024 · 75.28
Debt ≤ 1 year
€128k
2024 · €127k
Income taxes
€152k
2024 · €102k
Staff costs
€39k
2024 · €32k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 53 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.31M€1.59M
Fixed assets21/28€88k€55k
Tangible fixed assets22/27€88k€55k
Land and buildings22€7k€6k
Plant, machinery and equipment23€79k€47k
Furniture and vehicles24€2k€2k
Current assets29/58€1.23M€1.53M
Stocks and contracts in progress3€61k€28k
Stocks30/36€61k€28k
Amounts receivable within one year40/41€4k€2k
Trade receivables40€4k€2k
Current investments50/53€580k€947k
Cash at bank and in hand54/58€576k€549k
Deferred charges and accrued income490/1€6k€5k
Equity and liabilities
Total equity and liabilities10/49€1.31M€1.59M
Equity10/15€1.19M€1.46M
Contributions10/11€12k€12k=
Reserves13€1.12M€1.38M
Non-distributable reserves130/1€0-
Reserves not available under the articles1311€0-
Distributable reserves133€1.12M€1.38M
Profit (loss) carried forward14€60k€60k=
Amounts payable17/49€127k€129k
Amounts payable within one year42/48€127k€128k
Trade debts44€3k€6k
Suppliers440/4€3k€6k
Taxes, remuneration and social security45€84k€58k
Taxes450/3€79k€53k
Remuneration and social security454/9€4k€5k
Other amounts payable47/48€40k€64k
Accrued charges and deferred income492/3-€495
Income statement Code20242025
Non-recurring operating income76A-€8k
Remuneration, social security and pensions62€32k€39k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€26k€18k
Other operating charges640/8€8k€2k
Non-recurring operating charges66A€205€2k
Gross operating margin9900€401k€525k
Operating profit (loss)9901€334k€463k
Financial income75/76B€2k€28k
Recurring financial income75€2k€28k
Financial charges65/66B€5k€3k
Recurring financial charges65€5k€3k
Profit (loss) for the period before taxes9903€331k€488k
Income taxes67/77€102k€152k
Profit (loss) for the period9904€229k€336k
Profit (loss) for the period to be appropriated9905€229k€336k
Appropriation of the result
Profit (loss) to be appropriated9906€289k€396k
Profit (loss) brought forward from the previous period14P€60k€60k=
Transfer from equity791/2€42k€67k
Transfer to equity691/2€229k€336k
To other reserves6921€229k€336k
Profit to be distributed694/7€42k€67k
Return on contributions (dividend)694€42k€67k

The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
14-01
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
30-06
Financial Highest result since 2019net €336k ▲47%
Operating result €463k, net result €336k, both a record.
2024
19-12
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2023
13-12
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
30-06
Financial Equity above €1MEq €1.00M ▲33%
5 profitable years in a row build equity to €1.00M.
2022
30-11
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2021
12-10
NBB filing Annual accounts filed
fiscal year 2021 · micro schema
30-04
Financial Equity above €500kEq €568k ▲42.8%
3 profitable years in a row build equity to €568k.
2020
14-10
NBB filing Annual accounts filed
fiscal year 2020 · micro schema
2019
28-11
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2018
30-11
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
2017
17-11
NBB filing Annual accounts filed
fiscal year 2017 · micro schema
2016
05-12
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 5 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Scherpenheuvel-Zichem · 1 establishment unit since 2018
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Basilieklaan 823270 Scherpenheuvel-Zichem
Ground area
462 m²
Building footprint
208 m²
Volume, LiDAR
1,887 m³
Parcel 24098A0372/00V000, Flanders · tallest building 13.5 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
DR. TEMPELS
Basilieklaan 82, 3270 Scherpenheuvel-ZichemHuman health activities
since 20182.276.266.732
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
24098A0372/00V000 Flanders 462 m² 1 · 208 m² 13.5 m · 4 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Public money · subsidies and aid

Flemish government

2024 · 1 entry · 402 EUR awarded · 402 EUR paid
Year Entries awardedpaid
2024 1 402 EUR402 EUR
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
1 entry · 402 EUR · 402 EUR paid · Fonds voor Innoveren en Ondernemen

Similar companies · same sector, comparable size

Of 9,124 companies in sector 86210 we hold annual accounts for 6,337. 3,505 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded30-05-1988
Fiscal year end30-06
Activities, NACEBEL
86210General medical practice
72109Other research and development on natural sciences
Sources
Crossroads Bank for EnterprisesNational Bank · 36 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.